Risk for stroke, death increased with each 10 mmol/mol increase in HbA1c level.
Low-dose statins may offer protective effect against osteoporosis.
Findings reported for composite outcomes for 1,905 patients with left main coronary artery disease
Risk up for severe, sometimes fatal, events, including supraventricular arrhythmias, CNS events
Risk for hospital admission increased for allopurinol-associated severe cutaneous adverse reactions
Correlation still significant after adjustment for other cardiovascular disease risk factors
Cardiorenal disease is commonly the first cardiovascular disease manifestation in patients with type 2 diabetes.
Linagliptin compared with glimepiride for risk for major cardiovascular events in T2DM with elevated CV risk
Over a median 5.1 years, similar proportions of patients who received monthly methoxy polyethylene glycol epoetin beta arm and a reference group treated with conventional ESAs experienced major cardiovascular events and death.
Greatest risk seen in first year of treatment, but benefits of combo therapy continue after one year